761 related articles for article (PubMed ID: 21586936)
1. Is there a role for fluorine 18 fluorodeoxyglucose-positron emission tomography and positron emission tomography/computed tomography in evaluating patients with mycobacteriosis? A systematic review.
Treglia G; Taralli S; Calcagni ML; Maggi F; Giordano A; Bonomo L
J Comput Assist Tomogr; 2011; 35(3):387-93. PubMed ID: 21586936
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of 18F-fluorodeoxyglucose positron emission tomography for diagnosing disease activity and monitoring therapeutic response in patients with pulmonary mycobacteriosis.
Demura Y; Tsuchida T; Uesaka D; Umeda Y; Morikawa M; Ameshima S; Ishizaki T; Fujibayashi Y; Okazawa H
Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):632-9. PubMed ID: 19093113
[TBL] [Abstract][Full Text] [Related]
3. The role of ¹⁸F-FDG PET or ¹⁸F-FDG-PET/CT in the evaluation of solitary pulmonary nodules.
Li W; Pang H; Liu Q; Zhou J
Eur J Radiol; 2015 Oct; 84(10):2032-7. PubMed ID: 26094866
[TBL] [Abstract][Full Text] [Related]
4. Atypical mycobacteriosis caused by Mycobacterium haemophilum in an immunocompromised patient: diagnosis by (18)F-FDG PET/CT.
Münster S; Zustin J; Derlin T
Clin Nucl Med; 2013 Apr; 38(4):e194-5. PubMed ID: 23455531
[TBL] [Abstract][Full Text] [Related]
5. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary mucosa-associated lymphoid tissue lymphoma: computed tomography and ¹⁸F fluorodeoxyglucose-positron emission tomography/computed tomography imaging findings and follow-up.
Zhang WD; Guan YB; Li CX; Huang XB; Zhang FJ
J Comput Assist Tomogr; 2011; 35(5):608-13. PubMed ID: 21926857
[TBL] [Abstract][Full Text] [Related]
7. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in gallbladder cancer: A meta-analysis.
Annunziata S; Pizzuto DA; Caldarella C; Galiandro F; Sadeghi R; Treglia G
World J Gastroenterol; 2015 Oct; 21(40):11481-8. PubMed ID: 26523112
[TBL] [Abstract][Full Text] [Related]
9. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography for the diagnosis of osteomyelitis related to diabetic foot: a systematic review and a meta-analysis.
Treglia G; Sadeghi R; Annunziata S; Zakavi SR; Caldarella C; Muoio B; Bertagna F; Ceriani L; Giovanella L
Foot (Edinb); 2013 Dec; 23(4):140-8. PubMed ID: 23906976
[TBL] [Abstract][Full Text] [Related]
11. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
Ozülker T; Ozülker F; Ozbek E; Ozpaçaci T
Nucl Med Commun; 2011 Apr; 32(4):265-72. PubMed ID: 21301376
[TBL] [Abstract][Full Text] [Related]
12. Dual-Energy Computed Tomography-Based Iodine Quantitation for Response Evaluation of Lung Cancers to Chemoradiotherapy/Radiotherapy: A Comparison With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Positron Emission Tomography/Computed Tomography Response Evaluation Criterion in Solid Tumors.
Ren Y; Jiao Y; Ge W; Zhang L; Hua Y; Li C; Zhai W; Tang X; He W; Fang M; Zheng X
J Comput Assist Tomogr; 2018; 42(4):614-622. PubMed ID: 29613988
[TBL] [Abstract][Full Text] [Related]
13. A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3'-deoxy-3'-18F-fluorothymidine and 18F-FDG.
Tian J; Yang X; Yu L; Chen P; Xin J; Ma L; Feng H; Tan Y; Zhao Z; Wu W
J Nucl Med; 2008 Feb; 49(2):186-94. PubMed ID: 18199618
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the assessment of pleural abnormalities in cancer patients: a systematic review and a meta-analysis.
Treglia G; Sadeghi R; Annunziata S; Lococo F; Cafarotti S; Prior JO; Bertagna F; Ceriani L; Giovanella L
Lung Cancer; 2014 Jan; 83(1):1-7. PubMed ID: 24290256
[TBL] [Abstract][Full Text] [Related]
15. Advances in imaging of tuberculosis: the role of ¹⁸F-FDG PET and PET/CT.
Vorster M; Sathekge MM; Bomanji J
Curr Opin Pulm Med; 2014 May; 20(3):287-93. PubMed ID: 24614238
[TBL] [Abstract][Full Text] [Related]
16. Disseminated nontuberculous mycobacterial infection mimic metastases on PET/CT scan.
Lin KH; Wang JH; Peng NJ
Clin Nucl Med; 2008 Apr; 33(4):276-7. PubMed ID: 18356668
[TBL] [Abstract][Full Text] [Related]
17. Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results.
Naswa N; Sharma P; Soundararajan R; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
Diagn Interv Radiol; 2013; 19(4):294-8. PubMed ID: 23439252
[TBL] [Abstract][Full Text] [Related]
18. The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review.
Treglia G; Annunziata S; Sobic-Saranovic D; Bertagna F; Caldarella C; Giovanella L
Acad Radiol; 2014 May; 21(5):675-84. PubMed ID: 24703482
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk of malignancy of focal incidental uptake detected by fluorine-18-fluorodeoxyglucose positron emission tomography in the parotid gland: a meta-analysis.
Treglia G; Bertagna F; Sadeghi R; Muoio B; Giovanella L
Eur Arch Otorhinolaryngol; 2015 Dec; 272(12):3617-26. PubMed ID: 25262193
[TBL] [Abstract][Full Text] [Related]
20. Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: a systematic review.
Treglia G; Taralli S; Giordano A
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):87-94. PubMed ID: 22117499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]